Subscribe To
Thrombectomy devices market value to surpass us$ 3.4 bn by 2031, as per tmr report
The rise in prevalence of cardiac disorders globally is anticipated to create lucrative opportunities i...
March 3, 2023, 5:30 am
Bioabsorbable stents market to exceed us$ 560.1 mn by 2031: tmr study
Significant utilization of bioabsorbable polymer-based stents, particularly to treat coronary artery diseases, is expected to offer substantial opport...
March 2, 2023, 11:30 pm
cardiff oncology (crdf) reports q4 loss, tops revenue estimates
cardiff Oncology (CRDF) delivered earnings and revenue surprises of 20% and 70.67%, respectively, for t...
March 2, 2023, 9:04 pm
Lightning round: cardinal health is a very good stock to own here
Mad Money host Jim Cramer weighs in on all manner of stocks, including CyberArk, Snowflake, cardinal He...
March 1, 2023, 8:09 pm
Is trending stock cardinal health, inc. (cah) a buy now?
cardinal (CAH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth explo...
February 28, 2023, 10:33 am
Dream-hf phase 3 trial results for mesoblast cell therapy in heart failure published in journal of the american college of cardiology (jacc)
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced publication of the...
February 27, 2023, 11:29 pm
Windtree announces istaroxime scientific abstract has been accepted at the 2023 technology and heart failure therapeutics conference
WARRINGTON, Pa., Feb. 27, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnolog...
February 27, 2023, 1:00 pm
cardiff oncology to present at the cowen 43rd annual health care conference
SAN DIEGO , Feb. 27, 2023 /PRNewswire/ -- cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biote...
February 27, 2023, 8:15 am
Merit medical: reasonably-priced execution, with m&a upside
Merit Medical delivered a modestly better than expected fourth quarter, with a little upside on revenue and a $0.02/share beat at the operating income...
February 25, 2023, 1:53 am
Cytosorbents to report fiscal 2022 operating and financial results
MONMOUTH JUNCTION, N.J. , Feb. 24, 2023 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening condit...
February 24, 2023, 7:00 am
Merit medical (mmsi) q4 earnings top estimates, margins down
Merit Medical (MMSI), in the fourth quarter, benefits from revenue growth in its cardiovascular segment...
February 23, 2023, 12:03 pm
Energy recovery, inc. (erii) q4 2022 earnings call transcript
Energy Recovery, Inc. (NASDAQ:ERII ) Q4 2022 Earnings Conference Call February 23, 2023 5:00 PM ET Company Participants Jim Sic...
February 22, 2023, 11:12 pm
cardinal health: downgrading due to absence of safety margin (rating downgrade)
cardinal Health, Inc.'s consistent fundamentals and growth prospects were reinforced by Q2 2023 earning...
February 21, 2023, 3:13 pm
Medtronic plc (mdt) q3 2023 earnings call transcript
Medtronic plc (NYSE:MDT ) Q3 2023 Earnings Conference Call February 21, 2023 8:00 AM ET Company Participants Ryan Weispfenning - Investor Relations Ge...
February 21, 2023, 12:29 pm
89bio to present additional pegozafermin data in severe hypertriglyceridemia from phase 2 entrigue study at american college of cardiology's annual scientific session together with world congress of c
SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and...
February 21, 2023, 8:00 am
89bio to present additional pegozafermin data in severe hypertriglyceridemia from phase 2 entrigue study at american college of cardiology's annual scientific session together with world congress of c
SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and...
February 21, 2023, 8:00 am
89bio to present additional pegozafermin data in severe hypertriglyceridemia from phase 2 entrigue study at american college of cardiology's annual scientific session together with world congress of c
SAN FRANCISCO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and...
February 21, 2023, 8:00 am
Medtronic tops third-quarter estimates as revenue boosted by strong cardiovascular and neuroscience portfolios
Medtronic Plc stock MDT, +0.71% rose in premarket trade Tuesday, after the medical device maker beat fiscal third-quarter consensus estimates. The Dub...
February 21, 2023, 6:56 am
Merck to present new data for sotatercept and mk-0616 at acc.23/wcc, demonstrating significant progress in advancing its innovative cardiovascular pipeline
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck to Present New Data for Sotatercept and MK-0616 at ACC....
February 21, 2023, 6:45 am
Warren buffett just broke 1 of his cardinal rules
Buffett's company Berkshire Hathaway is known as a long-term investor. But it didn't stick to this rule in the fourth quarter of 2022....
February 19, 2023, 7:23 am